list of fda approved glp-1 receptor agonists Market Overview: and the Obesity Market | Blog The Boom in New Weight

J Clin Invest 117:21552163 Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K (2009) Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function

Diabetes Res Clin Pract (1992) 15:97102

Moreover, as these mechanisms of action may occur concurrently, it is important to investigate alterations in drug exposure when multiple mechanisms are considered simultaneously

Ozempic and Wegovy both contain semaglutide, but they represent different approved use contexts and different access pathways

The 2024 average AOM semaglutide prescription rate amongst adolescents with obesity was 23.7-fold higher than the 2024 average AOM liraglutide prescription rate

Our BEAM, PRYZM, and CTLYST platforms provide critical insights for identifying development programs, acquisition targets, and investment opportunities